Gapping down
In reaction to disappointing earnings/guidance: CSLT -11.5%, NLST -11.5%, (announces common stock offering, sees Q4 below estiamtes), KEYW -9.2%, EOG -7.8%, CYBE -6.5%, CDE -5.8%, SCTY -5.2%, CBB -4.5%, REXX -4.1%, LINE -3.9%, BGS -3.6%, YUME -3.4%, SUNE -2.9%, VNDA -2.7%, TS -2.6%, DAVE -2.6%, DAN -2.5%, DENN -2.3%, AIMC -2.1%, RGLS -1.5%,PWR -1.4%, PCYC -1.3%, REMY -1.1%, AGI -1%
Select oil/gas related names showing early weakness: OAS -4.9%, WLL -4.7%, GDP -4.6%, SD -4.3%, SDRL -3.6%, STO -3.6%, PWE -3.3%, PBR -3.3%, WTI -3.1%, OXY -2.4%, TOT -2.3%, SLB -2.3%, COP -2.3%, HAL -2.1%, RIG -2.1%, CRZO -2%, CHK -1.9%
Other news: OCRX -20% (announces preliminary topline results from Phase 2a investigator-sponsored study evaluating OCR-002; data demonstrated a favorable safety profile), NLST -11.5% (priced an underwritten public offering of 7,692,308 shares of its common stock at a price to public of $1.30 per share), GENE -5% (cont strength), NGL -2.3% (announces decision to increase the size of its Grand Mesa Pipeline to a 20 inch capacity design; capable of transporting over 200K barrels/day), ACT -2.2% (files mixed securities shelf offering), ANGI -2.1% (after 60% jump yesterday following earnings), TI -1.1% (may buy remaining Telecom SpA stake, according to Bloomberg)
Analyst comments: PCYC -1.3% (downgraded to Neutral from Overweight at JP Morgan), PLCE -1.1% (downgraded to Hold from Buy at Maxim Group
)
In reaction to disappointing earnings/guidance: CSLT -11.5%, NLST -11.5%, (announces common stock offering, sees Q4 below estiamtes), KEYW -9.2%, EOG -7.8%, CYBE -6.5%, CDE -5.8%, SCTY -5.2%, CBB -4.5%, REXX -4.1%, LINE -3.9%, BGS -3.6%, YUME -3.4%, SUNE -2.9%, VNDA -2.7%, TS -2.6%, DAVE -2.6%, DAN -2.5%, DENN -2.3%, AIMC -2.1%, RGLS -1.5%,PWR -1.4%, PCYC -1.3%, REMY -1.1%, AGI -1%
Select oil/gas related names showing early weakness: OAS -4.9%, WLL -4.7%, GDP -4.6%, SD -4.3%, SDRL -3.6%, STO -3.6%, PWE -3.3%, PBR -3.3%, WTI -3.1%, OXY -2.4%, TOT -2.3%, SLB -2.3%, COP -2.3%, HAL -2.1%, RIG -2.1%, CRZO -2%, CHK -1.9%
Other news: OCRX -20% (announces preliminary topline results from Phase 2a investigator-sponsored study evaluating OCR-002; data demonstrated a favorable safety profile), NLST -11.5% (priced an underwritten public offering of 7,692,308 shares of its common stock at a price to public of $1.30 per share), GENE -5% (cont strength), NGL -2.3% (announces decision to increase the size of its Grand Mesa Pipeline to a 20 inch capacity design; capable of transporting over 200K barrels/day), ACT -2.2% (files mixed securities shelf offering), ANGI -2.1% (after 60% jump yesterday following earnings), TI -1.1% (may buy remaining Telecom SpA stake, according to Bloomberg)
Analyst comments: PCYC -1.3% (downgraded to Neutral from Overweight at JP Morgan), PLCE -1.1% (downgraded to Hold from Buy at Maxim Group
)